2004
DOI: 10.1086/422999
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Efficacy of Intramuscular Vaccinia Immune Globulin: A Literature Review

Abstract: Although controlled clinical trials do not exist to support the use of VIG for treatment of vaccinia-related complications or prophylaxis among individuals with contraindications to smallpox vaccination, available data suggest that VIG reduces morbidity and mortality associated with progressive vaccinia (vaccinia necrosum) and eczema vaccinatum. Furthermore, VIG seems to prevent vaccinial superinfection in patients with inflammatory skin diseases or burns, given the low incidence of vaccina-related complicatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
80
0
2

Year Published

2006
2006
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 80 publications
(82 citation statements)
references
References 45 publications
0
80
0
2
Order By: Relevance
“…T he humoral immune response is a major correlate of protection for poxvirus infection (1)(2)(3)(4)(5)(6)(7)(8), as well as many infectious agents (reviewed in Ref. 9).…”
mentioning
confidence: 99%
“…T he humoral immune response is a major correlate of protection for poxvirus infection (1)(2)(3)(4)(5)(6)(7)(8), as well as many infectious agents (reviewed in Ref. 9).…”
mentioning
confidence: 99%
“…Neutralizing antibodies are of primary importance in the protection from smallpox provided by the smallpox vaccine in animal models (6,25,33,64) and humans (4). Vaccinia immune globulin (VIG) has been shown to be an effective treatment against smallpox (45) as it was able to reduce the number of smallpox cases by ϳ80% among exposed individuals in four case-controlled studies (42,45,50,51,66).Neutralizing antibodies confer protection mainly through the recognition of structures on the surface of virus particles, and therefore antiviral antibodies directed against the surface of virions are of primary interest. There are several interesting features and problems of the antibody response to variola and related poxviruses, including the large size of the viral particles and the abundance of distinct surface proteins (Ͼ25 total) (17,70,88).…”
mentioning
confidence: 99%
“…With animal models (6,15,18,36) and in human clinical studies (28,37,53,60), there are substantial data demonstrating the important role of antibodies in protecting against smallpox and related poxviruses (5). The most compelling animal model data came from a recent monkeypox study with macaques, demonstrating that smallpox vaccine-induced antibody responses are both necessary and sufficient for protection against lethal monkeypox infection while memory T cells were dispensable (15).…”
mentioning
confidence: 99%
“…Long-term antibody titers and T-cell memory for the smallpox vaccine do not correlate in humans (11,19), excluding the possibility that antibody titers were simply a biomarker for memory T cells. Vaccinia immune globulin (VIG) is an effective treatment against smallpox (28), since it was able to reduce the number of smallpox cases ϳ80% among exposed individuals in four case-controlled studies (25,28,32,33,38).…”
mentioning
confidence: 99%